Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02032 | 34525124 | PLoS One | Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH). | 2021 | Details |
| A02033 | 34524971 | Endocr Connect | IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study. | 2021 | Details |
| A02034 | 34524919 | AIDS Patient Care STDS | Liver Fat, Adipose Tissue, and Body Composition Changes After Switching from a Protease Inhibitor or Efavirenz to Raltegravir. | 2021 | Details |
| A02035 | 34524608 | Hepatol Int | Non-alcoholic fatty liver disease frequency and associated factors at admission of acute stroke. | 2021 | Details |
| A02036 | 34524512 | Histochem Cell Biol | Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver. | 2021 | Details |
| A02037 | 34524028 | J Med Food | Black Mulberry Extract Elicits Hepatoprotective Effects in Nonalcoholic Fatty Liver Disease Models by Inhibition of Histone Acetylation. | 2021 | Details |
| A02038 | 34523235 | Liver Int | Relationship between drinking frequency and fatty liver prevalence or incidence in Japanese undergoing health checkup in 2008-2019. | 2021 | Details |
| A02039 | 34523053 | Inflammation | Hepatic Macrophages Express Melanoma Differentiation-Associated Gene 5 in Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02040 | 34522969 | J Nutr | Intake of Nuts and Seeds Is Associated with a Lower Prevalence of Nonalcoholic Fatty Liver Disease in US Adults: Findings from 2005-2018 NHANES. | 2021 | Details |
| A02041 | 34522873 | EClinicalMedicine | Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART). | 2021 | Details |
| A02042 | 34522493 | Cureus | The Role of Vitamins in Non-Alcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A02043 | 34521905 | Sci Rep | Development of a highly sensitive chemiluminescent enzyme immunoassay for fragmented cytokeratin 18 using new antibodies. | 2021 | Details |
| A02045 | 34521466 | Trials | Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial. | 2021 | Details |
| A02046 | 34521354 | Environ Health Prev Med | The association between urinary bisphenol A levels and nonalcoholic fatty liver disease in Korean adults: Korean National Environmental Health Survey (KoNEHS) 2015-2017. | 2021 | Details |
| A02047 | 34521152 | Liver Int | Higher dietary insulinaemic potential is associated with increased risk of liver steatosis and fibrosis. | 2021 | Details |
| A02050 | 34520731 | Arch Biochem Biophys | Beneficial effects of inorganic nitrate in non-alcoholic fatty liver disease. | 2021 | Details |
| A02052 | 34519576 | Radiology | Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study. | 2021 | Details |
| A02054 | 34519101 | Hepatology | The RNA binding protein human antigen R is a gatekeeper of liver homeostasis. | 2021 | Details |
| A02055 | 34519030 | Eur J Clin Invest | Hydrogen sulphide in liver glucose/lipid metabolism and non-alcoholic fatty liver disease. | 2021 | Details |
| A02056 | 34517467 | Zhonghua Gan Zang Bing Za Zhi | [Research progress on non-alcoholic fatty liver disease animal models]. | 2021 | Details |
| A02057 | 34517466 | Zhonghua Gan Zang Bing Za Zhi | [New development for targeted therapy of non-alcoholic fatty liver disease with thyroid hormone receptor beta]. | 2021 | Details |
| A02058 | 34517451 | Zhonghua Gan Zang Bing Za Zhi | [Emphasizing the mutual effects of metabolic-associated fatty liver disease with infectious disease]. | 2021 | Details |
| A02059 | 34517014 | Metabolism | Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes. | 2021 | Details |
| A02060 | 34516703 | Int J Clin Pract | Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial. | 2021 | Details |
| A02061 | 34516586 | PLoS One | The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus. | 2021 | Details |
| A02062 | 34516075 | ACS Appl Mater Interfaces | Quantitative Structure-Activity Relationship Enables the Rational Design of Lipid Droplet-Targeting Carbon Dots for Visualizing Bisphenol A-Induced Nonalcoholic Fatty Liver Disease-like Changes. | 2021 | Details |
| A02063 | 34515137 | J Innate Immun | The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02064 | 34513923 | Front Mol Biosci | The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis and Inflammation in Experimental Murine Non-Alcoholic Steatohepatitis. | 2021 | Details |
| A02065 | 34513896 | Front Med (Lausanne) | The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A02066 | 34513769 | Front Pediatr | Comparison of Body Mass Index and Fat Indices in Predicting the Severity of Nonalcoholic Fatty Liver Disease Among Children Who Are Overweight and Obese. | 2021 | Details |
| A02067 | 34512784 | Evid Based Complement Alternat Med | Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation. | 2021 | Details |
| A02068 | 34512330 | Front Pharmacol | Network Pharmacology-Based Analysis on the Potential Biological Mechanisms of Sinisan Against Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A02069 | 34511825 | J Clin Exp Hepatol | Recurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis-A Case Report. | 2020 | Details |
| A02070 | 34511823 | J Clin Exp Hepatol | Hereditary Persistence of Alpha-Fetoprotein in Chronic Liver Disease-Confusing Genes! | 2020 | Details |
| A02071 | 34511822 | J Clin Exp Hepatol | Hepatogenous Diabetes: A Primer. | 2021 | Details |
| A02072 | 34511820 | J Clin Exp Hepatol | Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography. | 2020 | Details |
| A02073 | 34511816 | J Clin Exp Hepatol | Primary Versus Secondary NAFLD: Perspective on Advanced Fibrosis. | 2020 | Details |
| A02074 | 34511814 | J Clin Exp Hepatol | Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors. | 2021 | Details |
| A02080 | 34511460 | Georgian Med News | [METABOLIC FEATURES OF ADIPOSE TISSUE AND CLINICAL SIGNIFICANCE OF ADIPOKINS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (REVIEW)]. | 2021 | Details |
| A02081 | 34511367 | Obes Res Clin Pract | Accuracy of ultrasound diagnosis of nonalcoholic fatty liver disease in patients with classes II and III obesity: A pathological image study. | 2021 | Details |
| A02082 | 34511051 | Benef Microbes | Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. | 2021 | Details |
| A02083 | 34511037 | Bioengineered | Long non-coding RNA AC012668 suppresses non-alcoholic fatty liver disease by competing for microRNA miR-380-5p with lipoprotein-related protein LRP2. | 2021 | Details |
| A02084 | 34511035 | Bioengineered | Lactobacillus johnsonii BS15 combined with abdominal massage on intestinal permeability in rats with nonalcoholic fatty liver and cell biofilm repair. | 2021 | Details |
| A02085 | 34510514 | Hepatology | Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice. | 2021 | Details |
| A02087 | 34509791 | Diabetes Metab Syndr | Serum microRNA-486-5p expression in obese Egyptian children and its possible association with fatty liver. | 2021 | Details |
| A02088 | 34509679 | World Neurosurg | Thrombocytopenia Associated with Unrecognized Non-Alcoholic Fatty Liver Disease Is an Independent Predictor of Perioperative Significant Blood Loss in Cervical Laminoplasty. | 2021 | Details |
| A02090 | 34509375 | Surg Obes Relat Dis | Bariatric surgery improves metabolic and nonalcoholic fatty liver disease markers in metabolically healthy patients with morbid obesity at 5 years. | 2021 | Details |
| A02094 | 34508810 | Pharmacol Res | GADD45β stabilized by direct interaction with HSP72 ameliorates insulin resistance and lipid accumulation. | 2021 | Details |
| A02095 | 34508791 | J Hepatol | Rational HCC screening approaches for patients with NAFLD. | 2021 | Details |
| A02096 | 34508671 | Lancet Gastroenterol Hepatol | Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02097 | 34508669 | Lancet Gastroenterol Hepatol | Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa. | 2021 | Details |
| A02098 | 34508601 | J Clin Endocrinol Metab | Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China. | 2022 | Details |
| A02099 | 34508436 | JNMA J Nepal Med Assoc | Carotid Intima-media Thickness in Patients with Non-alcoholic Fatty Liver Disease Attending a Tertiary Care Center: A Descriptive Cross-sectional Study. | 2021 | Details |
| A02100 | 34508238 | Nat Rev Gastroenterol Hepatol | Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. | 2021 | Details |
| A02101 | 34508113 | Sci Rep | Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. | 2021 | Details |
| A02102 | 34507895 | Dig Liver Dis | The safety and efficacy evaluation of Sodium-Glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty Liver disease: An updated meta-analysis. | 2021 | Details |
| A02103 | 34506332 | Clin Transl Gastroenterol | The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. | 2021 | Details |
| A02104 | 34506234 | Adipocyte | A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease. | 2021 | Details |
| A02105 | 34505899 | Nephrol Dial Transplant | Prevalence of non-alcoholic fatty liver disease in patients with chronic kidney disease: a case-control study. | 2021 | Details |
| A02106 | 34505434 | Se Pu | [Identification of LAMTOR1-regulated metabolites using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry in malignant transformation of liver inflammation]. | 2021 | Details |
| A02107 | 34505423 | Endocrinol Diabetes Metab | Oxy210, a novel inhibitor of hedgehog and TGF-β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice. | 2021 | Details |
| A02108 | 34504563 | Exp Ther Med | Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR. | 2021 | Details |
| A02109 | 34504179 | Sci Rep | Association between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease. | 2021 | Details |
| A02110 | 34503976 | Mol Pharmacol | Construction and Characterization of CRISPR/Cas9 Knockout Rat Model of Carboxylesterase 2a Gene. | 2021 | Details |
| A02111 | 34503201 | Cancers (Basel) | Lipid Droplet-Associated Factors, PNPLA3, TM6SF2, and HSD17B Proteins in Hepatopancreatobiliary Cancer. | 2021 | Details |
| A02112 | 34503151 | Cancers (Basel) | Host-Microbiota Interactions in Liver Inflammation and Cancer. | 2021 | Details |
| A02113 | 34502347 | Int J Mol Sci | Molecular Imaging of Brown Adipose Tissue Mass. | 2021 | Details |
| A02114 | 34502047 | Int J Mol Sci | Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. | 2021 | Details |
| A02115 | 34501590 | Int J Environ Res Public Health | Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study. | 2021 | Details |
| A02116 | 34501508 | Int J Environ Res Public Health | Relationships of Dietary Habits and Physical Activity Status with Non-Alcoholic Fatty Liver Disease Featuring Advanced Fibrosis. | 2021 | Details |
| A02117 | 34501231 | J Clin Med | Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies. | 2021 | Details |
| A02118 | 34500407 | Curr Opin Pharmacol | A double-edged sword: The Kelch-like ECH-associated protein 1-nuclear factor erythroid-derived 2-related factor 2-antioxidant response element pathway targeted pharmacological modulation in nonalcoholic fatty liver disease. | 2021 | Details |
| A02119 | 34499619 | J Clin Invest | Cannabinoid receptor 1 signaling in hepatocytes and stellate cells does not contribute to NAFLD. | 2021 | Details |
| A02120 | 34499435 | Hepatol Commun | What Does the Future Hold for Patients With Nonalcoholic Steatohepatitis: Diagnostic Strategies and Treatment Options in 2021 and Beyond? | 2021 | Details |
| A02121 | 34498502 | Ann Med | High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China. | 2021 | Details |
| A02122 | 34498413 | Pediatr Obes | Recent advances in the epidemiology of nonalcoholic fatty liver disease in children. | 2021 | Details |
| A02123 | 34498307 | Phytother Res | The effect of pomegranate extract on anthropometric indices, serum lipids, glycemic indicators, and blood pressure in patients with nonalcoholic fatty liver disease: A randomized double-blind clinical trial. | 2021 | Details |
| A02124 | 34497708 | Ther Adv Endocrinol Metab | Therapeutic approaches for non-alcoholic steatohepatitis. | 2021 | Details |
| A02125 | 34497507 | Front Aging Neurosci | Cardiometabolic Modification of Amyloid Beta in Alzheimer's Disease Pathology. | 2021 | Details |
| A02126 | 34497431 | World J Gastroenterol | Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. | 2021 | Details |
| A02127 | 34497333 | Sci Rep | Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease. | 2021 | Details |
| A02128 | 34496884 | Lipids Health Dis | Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis. | 2021 | Details |
| A02129 | 34496264 | J Ethnopharmacol | Mechanism by which Eucommia ulmoides leaves Regulate Nonalcoholic fatty liver disease based on system pharmacology. | 2021 | Details |
| A02130 | 34496054 | Hepatology | Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis. | 2021 | Details |
| A02131 | 34495059 | Rev Assoc Med Bras (1992) | The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. | 2021 | Details |
| A02132 | 34494551 | JCI Insight | Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation. | 2021 | Details |
| A02133 | 34494384 | Hepatol Commun | Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis. | 2021 | Details |
| A02134 | 34493216 | BMC Nephrol | Association of elevated serum aminotransferase levels with chronic kidney disease measures: hispanic community health study/study of latinos. | 2021 | Details |
| A02135 | 34493137 | Expert Rev Gastroenterol Hepatol | Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review. | 2021 | Details |
| A02136 | 34492534 | Int Immunopharmacol | Antcin A alleviates pyroptosis and inflammatory response in Kupffercells of non-alcoholic fatty liver disease by targeting NLRP3. | 2021 | Details |
| A02137 | 34491886 | Gut Microbes | Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study. | 2022 | Details |
| A02138 | 34491336 | J Clin Endocrinol Metab | Nonalcoholic Fatty Liver Disease in Women and Girls With Polycystic Ovary Syndrome. | 2022 | Details |
| A02139 | 34490745 | Pediatr Obes | Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children. | 2021 | Details |
| A02140 | 34490362 | Front Cardiovasc Med | The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study. | 2021 | Details |
| A02141 | 34490309 | Front Med (Lausanne) | Effects of Telemedicine on Obese Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A02142 | 34489524 | Int J Obes (Lond) | Leptin resistance before and after obesity: evidence that tissue glucose uptake underlies adipocyte enlargement and liver steatosis/steatohepatitis in Zucker rats from early-life stages. | 2021 | Details |
| A02143 | 34489307 | Gut | Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. | 2021 | Details |
| A02144 | 34488621 | Mol Med | MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice. | 2021 | Details |
| A02145 | 34487087 | Acta Biomed | The Prevalence of the Different Components of the Metabolic Syndrome (MetS) in Obese Nondiabetic Children and Young Adolescents and their Anthropometric Data in Relation to Parents. | 2021 | Details |
| A02146 | 34486981 | Endocr Connect | Nonalcoholic steatohepatitis: global impact and clinical consequences. | 2021 | Details |